Feb 27, 2025, 11:44 | Blog

Homa Dadras: Georgina Long on neoadjuvant immunotherapy for Melanoma patients

Homa Dadras, Research Assistant at Keck School of Medicine of USC, posted on X: "Incredible…

Feb 27, 2025, 10:35 | Blog

Benjamin Schrank: An antibody-toxin conjugate that enhances immune recognition of tumors

Benjamin Schrank, Radiation Oncology Resident at MD Anderson Cancer Center, posted on X about recent paper…

Feb 23, 2025, 15:46 | Drugs

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Tebentafusp (brand name KIMMTRAK) is a first-in-class bispecific T-cell receptor (TCR) fusion protein designed to…

Feb 16, 2025, 22:07 | Blog

Susanna Fletcher Greer: What I wish you knew about research in melanoma

Susanna Fletcher Greer, Chief Scientific Officer at the V Foundation, shared a post on LinkedIn: "What I…

Feb 10, 2025, 07:52 | Oncolibrary,Oncologist Near Me

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

Oncologist Near Me: Lynn Schuchter Welcome to OncoDaily's special section “Oncologist Near Me” where we introduce prominent…

Feb 9, 2025, 17:22 | Blog

Paolo A. Ascierto: From melanoma to kidney cancer, vaccine research is making significant strides

Paolo A. Ascierto, Director of Department Melanoma at Cancer Immunotherapy and Development Therapeutics, shared a…

Feb 3, 2025, 13:46 | Blog

Özcan Met: The first patient with melanoma received TILs edited with non-viral CRISPR technology

Özcan Met, Associate Professor and Head of Cell Therapy Unit at National Center for Cancer…

Feb 3, 2025, 05:38 | Blog

Antonio M. Grimaldi: Proud to be at the V International Ankara Hematology and Oncology Congress

Antonio M. Grimaldi, Director of U.O.C. Oncology at AORN San Pio, shared a post on…

Jan 28, 2025, 17:20 | Blog

Melanoma clinical trial ME17 is officially open for enrollment in Canada - Canadian Cancer Trials Group

Canadian Cancer Trials Group shared a post on LinkedIn: "Melanoma clinical trial ME17 is officially…

Jan 23, 2025, 12:49 | Blog

Paolo Ascierto: Pembrolizumab indication extended for neoadjuvant therapy in melanoma

Paolo Ascierto, Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics at RCCS National…

Jan 21, 2025, 06:35 | Blog

Leading experts reviewing practice-changing publications in HCC and stage III melanoma - ESMO

European Society for Medical Oncology shared a post on LinkedIn: "Practice-changing publications in HCC and…

Jan 6, 2025, 14:52 | Blog

E.Senthil Kumar: From Shadows to Solutions - The Revolution Against Cancer

E.Senthil Kumar, Medical Oncologist at Red Hills, Chennai, shared a post on X: "From Shadows…

Jan 5, 2025, 14:23 | Science

Andrea Boutros: Can fewer cycles of immunotherapy deliver the same results?

Andrea Boutros, a Medical Doctor and Oncology Resident at San Martino Polyclinic Hospital shared a…

Dec 31, 2024, 09:39 | Insight

NFCR joins the nation in mourning the passing of former President James (Jimmy) Carter

National Foundation for Cancer Research (NFCR) shared on LinkedIn: “The National Foundation for Cancer Research…

Dec 30, 2024, 06:41 | Insight

Tom Powles: TIGIT and LAG3 targets have been explored

Tom Powles, Professor at the University of London, posted the following on X: “TIGIT and…

Dec 28, 2024, 13:49 | Insight

Timothée Olivier: What is the best 1st line immunotherapy regimen for patients with advanced/meta melanoma?

Timothée Olivier, Medical oncologist at the Oncology Division of Geneva University, shared a recent article…

Dec 23, 2024, 11:45 | Dialogues

Dr. Jason Luke's Journey in Immuno-Oncology Innovation

In this episode of OncoDaily, Dr. Jason J. Luke, a leading expert in Malignant Hematology…

Dec 18, 2024, 11:36 | Blog

New Article on OncoDaily Medical Journal by Agop Y. Bedikian

The OncoDaily Medical Journal has published a new review article by Agop Y. Bedikian. Shushan…

Dec 17, 2024, 01:16 | Blog

Paolo Tarantino: LAG3 blockade adds upon PD1 blockade in melanoma

Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post by Akhil Santhosh,…

Dec 15, 2024, 10:40 | Blog

Jonathan Cohen: Adjuvant therapy in melanoma remains complex

Jonathan Cohen, Director of Clinical Research at Sharett Institute of Oncology of Hadassah Medical Center,…

Dec 15, 2024, 09:03 | Blog

Sami (Papacek) Mansfield: Honored to be a panelist at the AIM at Melanoma Foundation's Inaugural Survivorship Symposium

Sami (Papacek) Mansfield shared on LinkedIn: "Cancer doesn’t take weekends off. Neither should we. Today, I…

Dec 14, 2024, 03:02 | Blog

OncoInfluencers to Follow on Social Media: Richard Scolyer

We’re excited to feature Professor Richard Scolyer, a distinguished leader in melanoma and skin cancer…

Dec 9, 2024, 14:46 | Blog

Andrea Boutros: Impact of Novel Systemic Immunotherapy and Targeted Therapies on Fertility in Melanoma Patients

Andrea Boutros, Medical Doctor and Oncology Resident at San Martino Polyclinic Hospital, shared a post…

Dec 9, 2024, 14:45 | Insight

Bettina Ryll: Valerie Diane Valeriano at MPNE Hubs 2024 on how the microbiome modulates response to immune therapies in Melanoma

Bettina Ryll, Founder of MPN Europe, shared on LinkedIn: "Listening to Valerie Diane Valeriano at…

Dec 8, 2024, 23:21 | Blog

Sami (Papacek) Mansfield: Are melanoma cancer survivors a forgotten group?

Sami (Papacek) Mansfield, The founder of Cancer Wellness for Life, posted on LinkedIn: "Are melanoma…

Dec 7, 2024, 11:11 | Blog

Important factors associated with risk of developing melanoma in Rhode Island by Oliver Wisco

Wafik S. El-Deiry shared a post on X: "Great presentation by Dr. Oliver Wisco at the…

Nov 26, 2024, 18:48 | Blog

Sylvester Comprehensive Cancer Center - The Beyer Family Skin Cancer Prevention and Control Initiative

Sylvester Comprehensive Cancer Center shared on LinkedIn: "Skin cancer is the most common type of cancer…

Nov 25, 2024, 08:02 | Blog

Jarushka Naidoo: Memorial Sloan Kettering Cancer Center reunion at Gathering Around Cancer 2024

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X: "Memorial Sloan…

Nov 13, 2024, 08:30 | Blog

Patrick Hwu: Exploring the unique partnership between Moffitt Cancer Center and Iovance Biotherapeutics

Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on LinkedIn: "Join…

Nov 8, 2024, 13:58 | Blog

Rashad Nawfal: Our work on the landscape of subsequent therapies in perioperative Immuno-oncology trials

Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on X about recent…

Nov 8, 2024, 12:37 | Positive

Jennifer Buell: Pioneering Leadership in Biotechnology

Dr. Jennifer Buell is a prominent figure in the biotechnology industry, currently serving as the…

Nov 7, 2024, 19:19 | Blog

Tracey O’Brien: Revealing the Top 25 Areas in NSW with Greatest Melanoma Burden

Tracey O’Brien, NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, shared a…

Nov 6, 2024, 04:41 | Insight

An increased risk of melanoma among individuals with variants of the MC1R gene associated with red hair

National Cancer Institute (NCI) shared a post on LinkedIn: “On National Redhead Day, we’re highlighting…

Nov 1, 2024, 05:37 | Immune Oncology

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Immunotherapy has revolutionized the treatment of melanoma, particularly for advanced or metastatic cases. By harnessing…

Oct 29, 2024, 21:00 | Positive

Steven O'Day: At the Forefront of Immunotherapy

Dr. Steven O'Day, an immunotherapy pioneer and medical oncologist, is the Chief Medical Officer at…

Oct 26, 2024, 08:58 | Dialogues

ASCO24 Updates: Dr. Jafar Al-Mondhiry on Psychosocial Oncology Education

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 26, 2024, 08:55 | Blog

Lisanne Zijlker on crossing borders on the treatment of melanoma and Merkel Cell Carcinoma

Winan van Houdt shared a post on LinkedIn: "Congratulations Lisanne Zijlker. She defended her PhD thesis…

Oct 23, 2024, 12:18 | Insight

Elvina Almuradova: Reasearch shows radioactive iodine increases skin cancer risk in thyroid cancer patients

Elvina Almuradova, Associate Professor at Medicana Health Group, shared the following post on LinkedIn: “Research…

Oct 17, 2024, 06:00 | Blog

Eric Lau: Another SMR24 Congress for the books

Eric Lau shared a post on X: "Another SMR24 Congress for the books! Great science,…

Oct 16, 2024, 13:56 | Blog

Naveen Pemmaraju: Celebrating emerging collaborations across the MD Anderson Cancer Center

Naveen Pemmaraju shared on X: ''Celebrating emerging collaborations across the MD Anderson Cancer Center Cancer…

Oct 16, 2024, 13:50 | Blog

Lynn Schuchter: Honoring the 10-year anniversary of Tara Miller’s passing

Lynn Schuchter shared a post on X: ''Today we honor the 10-year anniversary of Tara…

Oct 14, 2024, 12:36 | Insight

Updated data of KEYNOTE-716 and CheckMate 76K studies at ESMO24

The European Society for Medical Oncology (ESMO) shared a post on X: "At ESMO24, updated…

Oct 12, 2024, 11:15 | Blog

Josh Neman: Advancing frontiers of Clinical Trials, policy and research for patient

Josh Neman shared on X: ''Fantastic brain metastasis think tank National Cancer Institute. Advancing frontiers…

Oct 12, 2024, 11:08 | Blog

Help Melanoma Research Foundation make a difference in the fight against melanoma

Melanoma Research Foundation shared a post on X: ''Help us make a difference in the…

Oct 9, 2024, 10:32 | Blog

Winan van Houdt: Welcoming guest surgeons from Prague and Cali to share knowledge on sarcoma and melanoma

Winan van Houdt posted the following on LinkedIn: “It is a pleasure to welcome our…

Oct 8, 2024, 12:29 | Insight

Valerie Yang: How should patients with advanced mucosal melanoma be treated?

Valerie Yang, Consultant Medical Oncologist, National Cancer Centre Singapore, shared a post on LinkedIn: "In…

Oct 7, 2024, 14:35 | Blog

Shushan Hovsepyan: OncoDaily Medical Journal is set to change the way in scientific publishing

Shushan Hovsepyan shared a post on X: "We’ve just received a new review article on melanoma…

Oct 5, 2024, 13:07 | Positive

Jimmy Carter at 100: A Legacy of Resilience and the Power of Immunotherapy

Jimmy Carter (James Earl Carter, Jr.), the thirty-ninth president of the United States, was born…

Oct 2, 2024, 13:10 | Dialogues

ASCO24 Updates: Dr. Fade Mahmoud on Neoadjuvant Immunotherapy and Evolving Melanoma Treatment Standards

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 29, 2024, 13:59 | Dialogues

European School of Oncology: Refresher Course in Melanoma Surgery

The refresher course on melanoma surgery, organized by the European School of Oncology, is aimed…

Sep 24, 2024, 12:50 | Dialogues

60 +1 Questions About Acute Lymphoblastic Leukemia in Children with Scott Howard

Professor Scott Howard is the Deputy Director at Yeolyan Hematology and Oncology Centerand the CEO…

Sep 23, 2024, 23:54 | Blog

Sylwia Biszczuk: Reflecting on the ESMO annual congress

Sylwia Biszczuk, Medical Network and Operations Manager at Further Group, posted on LinkedIn: "As we are…

Sep 20, 2024, 18:09 | Blog

Marco Donia: Melanoma at ESMO24

Marco Donia posted on LinkedIn: "Melanoma at ESMO24 (Mini Oral Session) My main take-home messages…

Sep 18, 2024, 23:30 | Blog

Sami Mansfield: Implementing the Six Pillars of lifestyle medicine to improve cancer outcomes

Sami (Papacek) Mansfield posted the following on LinkedIn: “This weekend I rounded up another lap…

Sep 16, 2024, 13:24 | Dialogues

OncoDaily: France Bureau // vol.1

Tatev-Sargsyan Lefort presents the latest oncology news roundup from the past week, with a focus…

Sep 14, 2024, 14:02 | Blog

Amol Akhade: Advanced cell therapy for solid tumors - Where do we stand?

Amol Akhade posted the following on LinkedIn: “I don’t know who should know this more…

Sep 13, 2024, 12:35 | Dialogues

MASCC Highlights: Surviving with Immunotoxicity | Christina Ruhlmann

In this episode of OncoDaily, Dr. Christina Ruhlmann, a clinical oncologist from Denmark, shares insights…

Sep 10, 2024, 13:42 | Blog

Vivek Subbiah: A morning walk to support melanoma research

Vivek Subbiah posted on X by himself adding: "Amazing day for a morning walk to…

Sep 9, 2024, 13:23 | Immune Oncology,Oncolibrary

Immunotherapy vs Chemotherapy: Success Rates, Side Effects, Costs Compared

When comparing immunotherapy vs chemotherapy, it's important to understand how these cancer treatments work differently.…

Sep 7, 2024, 04:34 | Insight

Iannis Aifantis: The role of stress response in NK cell-mediated antitumor immunity

Iannis Aifantis, Chairman of Department of Pathology, NYU School of Medicine shared a post on…

Sep 6, 2024, 09:00 | Blog

Updates in Immunotherapy for Cutaneous Sarcomas with Maurício Ribeiro at Sírio-Libanês Hospital Grand Rounds

Maurício Ribeiro posted on X: "Glad to have had the opportunity to discuss updates in…

Sep 2, 2024, 19:15 | Insight

Patrick Hwu: How does anti-CTLA-4 and anti-PD-1 combination work mechanistically?

Patrick Hwu shared a post on LinkedIn: “The combination of anti-CTLA-4 and anti-PD-1 antibodies is…

Sep 1, 2024, 10:46 | Insight

Article of the day, September 1st, suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…

Aug 30, 2024, 12:14 | Stories

Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention

Heman Bekele, a 14-year-old from Virginia, developed a bar of soap called Skin Cancer Treating…

Aug 30, 2024, 10:39 | Insight

Article of the day, August 30th, suggested by the Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…

Aug 29, 2024, 15:37 | Career

Proposals for Team Science Award and Established Investigator Award for Pediatric Melanoma - St. Baldrick's Foundation

St. Baldrick's Foundation shared on LinkedIn: "In partnership with the Melanoma Research Alliance, we’re excited…

Aug 28, 2024, 05:03 | Insight

Individualized cancer therapy boosts immune activity - Mass General Cancer Center

Mass General Cancer Center shared a post on X: “A study led by researchers at…

Aug 26, 2024, 21:02 | Blog

Francesco Schettini: NGS of Actionable Genomic Alterations in Solid Tumors

Francesco Schettini, Medical Oncologist at the Breast Unit of the Hospital Clinic of Barcelona, posted…

Aug 26, 2024, 20:20 | Blog

Tanja Obradovic: Some points of interest from the Relativity-104 study

Tanja Obradovic shared on LinkedIn: "Opdualag, a cocktail of anti Lag-3 (relatlimab) and anti PD1…

Aug 23, 2024, 06:22 | Blog

Highlights from the 2024 Seattle Cellular Therapy Summit

The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…

Aug 22, 2024, 17:45 | Dialogues

Beyond the Cancer Diagnosis: Dialogue with Dr. Alberto Costa, Hosted by Adrian Pogacian

In this new episode of ‘Beyond the Cancer Diagnosis’, Adrian Pogacian underlines the importance of…

Aug 22, 2024, 13:30 | Blog

Danielle Fournier: Content Experts Needed for the ONS Biomarker Database

Danielle Fournier, Advanced Practice Registered Nurse in the Department of Thoracic and Cardiovascular Surgery at…

Aug 22, 2024, 04:59 | Blog

Honoring Jeff Weber, a giant in the field of oncology

Jeffrey S. Weber, MD, PhD, a 2016 Giants of Cancer Care awardee in Melanoma, passed…

Aug 21, 2024, 14:43 | Blog

Science Saturday of anti-LAG-3 and anti-PD1 for advance melanoma with Patrick Hwu

Patrick Hwu shared a post on X: "The combination of anti-LAG-3 and anti-PD1 antibodies is US…

Aug 21, 2024, 14:16 | Blog

EORTC - Understanding long-term quality of life after completion of an adjuvant treatment for melanoma

EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn: " Have you…

Aug 21, 2024, 14:03 | Blog

$3 million research grant to Dana-Farber Cancer Institute and UT Health San Antonio to study BRCA therapy

Dana-Farber Cancer Institute shared on LinkedIn: "Scientists at Dana-Farber's Center for BRCA and Related Genes in…

Aug 17, 2024, 12:25 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Julia Lai-Kwon

We are excited to spotlight Dr. Julia Lai-Kwon, a prominent figure in the oncology community,…

Aug 16, 2024, 19:45 | Insight

Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma

Jarushka Naidoo shared a post on X: "SYK signature predicts irAEs from adjuv ICI in melanoma…

Aug 14, 2024, 13:06 | Blog

Jennifer Marks: Treatment of melanoma from ASCO guidelines

Jennifer Marks, Thoracic Oncologist at Georgetown Lombardi, shared a post on X: “Treatment of melanoma…

Aug 11, 2024, 12:43 | Blog

Oncology Brothers: Melanoma Treatment Algorithm with Allison Betof Warner

Rahul Gosain posted on LinkedIn: "Melanoma: with Allison Betof Warner we the SoC for early, locally…

Aug 11, 2024, 02:13 | Societies

12 Posts Not To Miss From Day 3 of ASCOBT24!

This Year the ASCO Breakthrough (ASCOBT24) was held in Yokohama, Japan from 8th to 10th of…

Aug 9, 2024, 12:57 | Insight

Tony Cillo: Excited to share our paper on anti-PD1+anti-LAG3 therapy in melanoma

Tony Cillo, Assistant professor in the Department of Immunology at the University of Pittsburgh. "Excited…

Aug 9, 2024, 09:25 | Blog

Jessica Plowman: For the first time, I’m done and out of school

Jessica Plowman posted on LinkedIn: "Last week I presented my final project of my master’s…

Aug 7, 2024, 16:37 | Blog

2024 ASCO Breakthrough Featured Voices

The ASCO Breakthrough conference, hosted by the American Society of Clinical Oncology (ASCO), is a…

Jul 26, 2024, 19:52 | Blog

Georgina Long: Beautiful Tasmania with Australian of the Year Awards spreading message of sun safety to kids

Georgina Long shared on X: "Beautiful Tasmania with Australian of the Year Awards. Spreading message…

Jul 25, 2024, 00:43 | Blog

Aaron Tallent: A new standard is poised to transform melanoma care

Aaron Tallent, Co-host of the Loaded Goat Podcast, shared on X: "A new standard is…

Jul 22, 2024, 07:49 | Blog

Tian Zhang: Best of ASCO Dallas 2024

Best of ASCO, an Official Annual Meeting Review of the American Society of Clinical Oncology…

Jul 21, 2024, 12:10 | Blog

invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma

invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…

Jul 19, 2024, 12:57 | Blog

Ahmad Tarhini: Important implications for drug development targeting the microbiome

Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute, shared…

Jul 19, 2024, 04:23 | Opinion

Dr. Lynn Schuchter on the vital work for Skin and Melanoma Cancers

Brenda Brody, Senior Vice President of Strategy/Client Services at PineRock, shared a post on LinkedIn…

Jul 17, 2024, 23:34 | Blog

What Sapna Patel hopes to bring to the CU Cancer Center

University of Colorado Cancer Center shared on LinkedIn: "'I’m so thrilled to be here,' says Sapna…

Jul 16, 2024, 15:33 | Blog

Latest advancements and research changing the landscape of melanoma - Conquer Cancer, the ASCO Foundation

Conquer Cancer, the ASCO Foundation shared on LinkedIn: "True or false? We're learning all about the…

Jul 15, 2024, 09:22 | Blog

Craig Bunnell: My 10th Pan-Mass Challenge ride

Craig Bunnell, Chief Medical Officer at Dana-Farber Cancer Institute, shared on LinkedIn: "It's that time of year…

Jul 11, 2024, 12:56 | Blog

Patrick Hwu: Dangers of melanoma

Patrick Hwu shared a post on X: . "Did you know that a majority of…

Jul 9, 2024, 08:38 | Insight

Maria Babak: FDA approval to lifileucel for advanced melanoma offers hope to those with limited options

Maria Babak shared a post by The Babak Lab on LinkedIn, adding: “This is a…

Jul 8, 2024, 05:44 | Insight

Sapna Patel: An important pathway in cancer signaling, including melanoma

The Video Journal of Oncology (VJOncology) shared on LinkedIn: "New from ASCO2024: Phase I trial…

Jul 1, 2024, 01:56 | Blog

Richard Scolyer: The Melanoma Institute Australia team remains committed to reach zero deaths from melanoma

Richard Scolyer shared a post on X: "The Melanoma Institute Australia team had a very…

Jun 27, 2024, 13:53 | Insight

ESO refresher course in melanoma surgery

European School of Oncology (ESO) shared a post on LinkedIn: “Are you interested in melanoma?…

Jun 25, 2024, 14:38 | Insight

New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results

Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results …

Jun 25, 2024, 04:14 | Blog

Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma at ecancer - Sarah Cannon Research Institute

Sarah Cannon Research Institute shared on LinkedIn: "Dr. Meredith McKean's recent discussion on PD-1–refractory advanced melanoma…